scholarly journals Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older

2018 ◽  
Vol 41 (10) ◽  
pp. 1211-1219 ◽  
Author(s):  
M. Majerczyk ◽  
P. Kocełak ◽  
P. Choręza ◽  
H. Arabzada ◽  
A. J. Owczarek ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Plasma Levels ◽  
Binding Protein ◽  
Retinol Binding Protein ◽  
Retinol Binding Protein 4

Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome

2008 ◽  
Vol 31 (11) ◽  
pp. 950-955 ◽  
Author(s):  
E. Diamanti-Kandarakis ◽  
S. Livadas ◽  
S. A. Kandarakis ◽  
I. Papassotiriou ◽  
A. Margeli
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Plasma Levels ◽  
Polycystic Ovary ◽  
Binding Protein ◽  
Retinol Binding Protein ◽  
Ovary Syndrome ◽  
Retinol Binding Protein 4 ◽  
Insulin Resistant ◽  
Free Plasma

scholarly journals Retinol-binding protein 4 expression in subcutaneous neck adipose tissue and serum in patients with and without metabolic syndrome

2016 ◽  
Author(s):  
Vlatka Pandzic Jaksic ◽  
Ana Livun ◽  
Danijela Grizelj ◽  
Drago Boscic ◽  
Marko Ajduk ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Adipose Tissue ◽  
Binding Protein ◽  
Retinol Binding Protein ◽  
Retinol Binding Protein 4

Retinol-binding protein 4 better correlates with metabolic syndrome than cystatin C

2018 ◽  
Vol 0 (0) ◽  
Author(s):  
Aleksandra Klisic ◽  
Nebojsa Kavaric ◽  
Ivan Soldatovic ◽  
Ana Ninic ◽  
Jelena Kotur-Stevuljevic
Keyword(s):  
Metabolic Syndrome ◽  
Postmenopausal Women ◽  
Cystatin C ◽  
Significant Relationship ◽  
Binding Protein ◽  
International Diabetes Federation ◽  
Retinol Binding Protein ◽  
Cross Sectional ◽  
Retinol Binding Protein 4 ◽  
Significant Difference

Abstract Background Retinol-binding protein 4 (RBP4) and cystatin C are regarded as novel metabolic risk markers. Therefore, we aimed to examine which one of these biomarkers better correlates with metabolic syndrome (MetS) in a cohort of postmenopausal women. Methods A total of 129 postmenopausal women (among which 62 women had MetS) were recruited in this cross-sectional study. MetS was diagnosed according to the International Diabetes Federation criteria. Results Cystatin C and RBP4 levels were significantly higher in women with MetS, compared to those without MetS (p=0.011 vs. p<0.001, respectively). A significant difference in the proportion of women with and without MetS across cystatin C and RBP4 quartiles was observed (χ2=5.1, p=0.025, and χ2=11.1, p=0.001, respectively). Logistic regression analysis revealed a borderline significant relationship between cystatin C and MetS (p=0.066), but this significance disappeared after adjustment for age, inflammation level and duration of menopause (p=0.221). On the contrary, a significant relationship between RBP4 and MetS was observed not only without adjustment (p=0.009), but also even after adjustment for age, inflammation level and duration of menopause (p=0.006). Conclusions RBP4 better correlates with MetS than cystatin C in postmenopausal women.

Sign in / Sign up

Export Citation Format

Share Document